FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035674583> ?p ?o ?g. }

• W3035674583 endingPage "1033" @default.
• W3035674583 startingPage "1023" @default.
• W3035674583 abstract "Outcomes associated with suboptimal use of antithrombotic treatments (antiplatelets, warfarin, direct oral anticoagulants [DOACs]) are unclear in Chinese patients with atrial fibrillation (AF). Our objective was to assess the prescription patterns, quality, effectiveness, and safety of antithrombotic treatments. This was a population-based cohort study using electronic health records in Hong Kong. Patients newly diagnosed with AF during 2010–2016 were followed up until 2017. Patients at high stroke risk (CHA2DS2-VASc score ≥ 2) and receiving antithrombotic treatments were matched using propensity scoring. We used Cox proportional hazards regression to compare the risks of ischemic stroke, intracranial hemorrhage (ICH), gastrointestinal bleeding (GIB), and all-cause mortality between groups. Of the 52,178 high-risk patients with AF, 27,614 (52.9%) received antithrombotic treatment and were included in the analyses. Between 2010 and 2016, prescribing of antiplatelets and warfarin declined and that of DOACs increased dramatically (from 1 to 32%). Two-thirds of warfarin users experienced poor anticoagulation control. Warfarin and DOACs were associated with lower risks of ischemic stroke (warfarin, hazard ratio [HR] 0.51 [95% confidence interval (CI) 0.36–0.71]; DOACs, HR 0.69 [95% CI 0.51–0.94]) and all-cause mortality (warfarin, HR 0.47 [95% CI 0.39–0.57]; DOACs, HR 0.45 [95% CI 0.37–0.55]) than were antiplatelets. DOACs were associated with a lower risk of ICH than was warfarin (HR 0.53 [95% CI 0.34–0.83]). GIB risks were similar among all groups. Antiplatelet prescribing and suboptimal warfarin management remain common in Chinese patients with AF at high risk of stroke. DOAC use may be associated with a lower risk of ischemic stroke and all-cause mortality when compared with antiplatelets and with a lower risk of ICH when compared with warfarin." @default.
• W3035674583 created "2020-06-19" @default.
• W3035674583 creator A5009388601 @default.
• W3035674583 creator A5025936391 @default.
• W3035674583 creator A5028633730 @default.
• W3035674583 creator A5033684035 @default.
• W3035674583 creator A5034498593 @default.
• W3035674583 creator A5035152212 @default.
• W3035674583 creator A5076157457 @default.
• W3035674583 creator A5080596908 @default.
• W3035674583 date "2020-06-18" @default.
• W3035674583 modified "2023-10-11" @default.
• W3035674583 title "Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study" @default.
• W3035674583 cites W1999468381 @default.
• W3035674583 cites W2012732196 @default.
• W3035674583 cites W2022726585 @default.
• W3035674583 cites W2040880477 @default.
• W3035674583 cites W2048470090 @default.
• W3035674583 cites W2085975373 @default.
• W3035674583 cites W2103245453 @default.
• W3035674583 cites W2121149747 @default.
• W3035674583 cites W2149388786 @default.
• W3035674583 cites W2182042465 @default.
• W3035674583 cites W2264353839 @default.
• W3035674583 cites W2310312828 @default.
• W3035674583 cites W2359956714 @default.
• W3035674583 cites W2475249835 @default.
• W3035674583 cites W2560173709 @default.
• W3035674583 cites W2588800208 @default.
• W3035674583 cites W2598097718 @default.
• W3035674583 cites W2864778399 @default.
• W3035674583 cites W2899289826 @default.
• W3035674583 cites W2912139642 @default.
• W3035674583 cites W2999886187 @default.
• W3035674583 cites W3004050106 @default.
• W3035674583 cites W3024237297 @default.
• W3035674583 doi "https://doi.org/10.1007/s40264-020-00961-0" @default.
• W3035674583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32557348" @default.
• W3035674583 hasPublicationYear "2020" @default.
• W3035674583 type Work @default.
• W3035674583 sameAs 3035674583 @default.
• W3035674583 citedByCount "5" @default.
• W3035674583 countsByYear W30356745832020 @default.
• W3035674583 countsByYear W30356745832021 @default.
• W3035674583 countsByYear W30356745832022 @default.
• W3035674583 countsByYear W30356745832023 @default.
• W3035674583 crossrefType "journal-article" @default.
• W3035674583 hasAuthorship W3035674583A5009388601 @default.
• W3035674583 hasAuthorship W3035674583A5025936391 @default.
• W3035674583 hasAuthorship W3035674583A5028633730 @default.
• W3035674583 hasAuthorship W3035674583A5033684035 @default.
• W3035674583 hasAuthorship W3035674583A5034498593 @default.
• W3035674583 hasAuthorship W3035674583A5035152212 @default.
• W3035674583 hasAuthorship W3035674583A5076157457 @default.
• W3035674583 hasAuthorship W3035674583A5080596908 @default.
• W3035674583 hasBestOaLocation W30356745832 @default.
• W3035674583 hasConcept C126322002 @default.
• W3035674583 hasConcept C127413603 @default.
• W3035674583 hasConcept C17923572 @default.
• W3035674583 hasConcept C207103383 @default.
• W3035674583 hasConcept C2776301958 @default.
• W3035674583 hasConcept C2777015399 @default.
• W3035674583 hasConcept C2778080469 @default.
• W3035674583 hasConcept C2779161974 @default.
• W3035674583 hasConcept C2780645631 @default.
• W3035674583 hasConcept C2908647359 @default.
• W3035674583 hasConcept C44249647 @default.
• W3035674583 hasConcept C71924100 @default.
• W3035674583 hasConcept C72563966 @default.
• W3035674583 hasConcept C78519656 @default.
• W3035674583 hasConcept C99454951 @default.
• W3035674583 hasConceptScore W3035674583C126322002 @default.
• W3035674583 hasConceptScore W3035674583C127413603 @default.
• W3035674583 hasConceptScore W3035674583C17923572 @default.
• W3035674583 hasConceptScore W3035674583C207103383 @default.
• W3035674583 hasConceptScore W3035674583C2776301958 @default.
• W3035674583 hasConceptScore W3035674583C2777015399 @default.
• W3035674583 hasConceptScore W3035674583C2778080469 @default.
• W3035674583 hasConceptScore W3035674583C2779161974 @default.
• W3035674583 hasConceptScore W3035674583C2780645631 @default.
• W3035674583 hasConceptScore W3035674583C2908647359 @default.
• W3035674583 hasConceptScore W3035674583C44249647 @default.
• W3035674583 hasConceptScore W3035674583C71924100 @default.
• W3035674583 hasConceptScore W3035674583C72563966 @default.
• W3035674583 hasConceptScore W3035674583C78519656 @default.
• W3035674583 hasConceptScore W3035674583C99454951 @default.
• W3035674583 hasIssue "10" @default.
• W3035674583 hasLocation W30356745831 @default.
• W3035674583 hasLocation W30356745832 @default.
• W3035674583 hasLocation W30356745833 @default.
• W3035674583 hasLocation W30356745834 @default.
• W3035674583 hasLocation W30356745835 @default.
• W3035674583 hasOpenAccess W3035674583 @default.
• W3035674583 hasPrimaryLocation W30356745831 @default.
• W3035674583 hasRelatedWork W115756687 @default.
• W3035674583 hasRelatedWork W1791055574 @default.
• W3035674583 hasRelatedWork W2037180721 @default.
• W3035674583 hasRelatedWork W2104343448 @default.

• next